News + Resources
Keep up with the latest
Featured
Epigenetic editors are a gentler form of gene editing
February 24, 2025
The Economist
Epigenetic editors are a gentler form of gene editing
February 24, 2025
Scribe Therapeutics Reports Preclinical Data Validating its CRISPR Genome Editing and Epigenome Modifying Technologies for Addressing Cardiometabolic Disease at American Heart Association (AHA) Scientific Sessions 2024
November 25, 2024
Scribe Therapeutics Reports Preclinical Data Validating its CRISPR Genome Editing and Epigenome Modifying Technologies for Addressing Cardiometabolic Disease at American Heart Association (AHA) Scientific Sessions 2024
November 25, 2024
All Stories
News
Scribe Therapeutics converting an Alameda shipway into a lab
July 30, 2022
The Real Deal
Read Now
Press Release
Scribe Therapeutics converting an Alameda shipway into a lab
July 30, 2022
The Real Deal
Read Now
Press Release
Scribe Therapeutics Announces Expansion of San Francisco Bay Area Headquarters, 3 Key Senior Hires
July 26, 2022
Read Now
Press Release
Scribe Therapeutics Announces Expansion of San Francisco Bay Area Headquarters, 3 Key Senior Hires
July 26, 2022
Read Now
Press Release
Scribe Therapeutics to Participate in SVB Securities Biopharma Private Company Connect
July 15, 2022
Read Now
Press Release
Scribe Therapeutics to Participate in SVB Securities Biopharma Private Company Connect
July 15, 2022
Read Now
News
How Jennifer Doudna's Life Has Changed Since Discovering CRISPR 10 Years Ago
July 1, 2022
TIME
Read Now
Press Release
How Jennifer Doudna's Life Has Changed Since Discovering CRISPR 10 Years Ago
July 1, 2022
TIME
Read Now